VENUSREMBSEVENUS REMEDIES LIMITEDHighNeutral
Announced Fri, 24 Jul · 18:50 IST

Annual Report FY26 filed, 37th AGM on Aug 20 with Rs.10 dividend

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.8%1-day move
₹1646.70
prior close
₹1649.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.9+0.1+0.1-6.8
Up moveDown movePending
AI summary

Venus Remedies filed FY 2025-26 Annual Report and 37th AGM notice for August 20, 2026 via video conferencing. Items include adoption of audited financials, final dividend of Rs.10 per share (100% on face value), cost auditor ratification at Rs.1.10 lakh plus taxes, appointment of Mr. Saransh Chaudhary as Whole-time Director at Rs.93 lakhs per annum, re-appointment of Dr. Manu Chaudhary as Joint MD at Rs.153.50 lakhs per annum, new Independent Director, and alteration of MOA and AOA. Dividend record date: August 7, 2026.

Likely market impact

Routine AGM filing with Rs.10 final dividend and key director appointments. Record date for dividend eligibility is August 7, 2026.